Skip to main content
OpenTrials

Clinical trial condition

Metastatic Solid Tumors

Explore clinical trials studying Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

56 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Solid Tumors trial results

Recruiting

A Study of DS3610a in Participants With Advanced Solid Tumor

NCT07159126

Conditions
Metastatic Solid Tumors, Solid Tumors
Locations
  • National Cancer Center Hospital Chūōku, Japan
  • National Cancer Center Hospital East Kashiwa, Japan
  • Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
  • Oncopole Claudius Regaud Toulouse, France
View Trial Details
Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 19 locations
View Trial Details
Recruiting

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

NCT06983743

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • Florida Cancer Specalists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital (MG) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

NCT07193511

Conditions
Locally Advanced, Metastatic Solid Tumors, Neoplasm Metastasis, +6 more
Locations
  • Avenzo Therapeutics Recruiting Site San Francisco, California, United States
  • Avenzo Therapeutics Recruiting Site Aurora, Colorado, United States
  • Avenzo Therapeutics Recruiting Site Orlando, Florida, United States
  • Avenzo Therapeutics Recruiting Site Tampa, Florida, United States
View all 14 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

NCT05836324

Conditions
Advanced Solid Tumors, Metastatic Solid Tumors, Solid Tumors
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cancer and Hematology Centers of Western Michigan-Start Midwest Grand Rapids, Michigan, United States
View all 39 locations
View Trial Details
Recruiting

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NCT07397338

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +22 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Dallas Irving, Texas, United States
View Trial Details
Recruiting

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

NCT07238075

Conditions
Advanced Malignancy, Advanced Solid Cancers, Chemically-Induced Disorders, +3 more
Locations
  • Macquarie University Sydney, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Sunshine Coast University Private Hospital Birtinya, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
View Trial Details

Related conditions